2.34
前日終値:
$2.41
開ける:
$2.4
24時間の取引高:
1.22M
Relative Volume:
0.65
時価総額:
$622.82M
収益:
$92.67M
当期純損益:
$-288.81M
株価収益率:
-2.1563
EPS:
-1.0852
ネットキャッシュフロー:
$-295.51M
1週間 パフォーマンス:
+2.63%
1か月 パフォーマンス:
+61.38%
6か月 パフォーマンス:
+28.57%
1年 パフォーマンス:
+33.71%
Autolus Therapeutics Plc Adr Stock (AUTL) Company Profile
Compare AUTL vs VRTX, REGN, ARGX, MRNA, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
AUTL
Autolus Therapeutics Plc Adr
|
2.34 | 654.76M | 92.67M | -288.81M | -295.51M | -1.0852 |
|
VRTX
Vertex Pharmaceuticals Inc
|
547.59 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
|
REGN
Regeneron Pharmaceuticals Inc
|
828.50 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
1,011.11 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
|
MRNA
Moderna Inc
|
138.89 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
|
RVMD
Revolution Medicines Inc
|
211.58 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Autolus Therapeutics Plc Adr Stock (AUTL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-17 | 開始されました | H.C. Wainwright | Buy |
| 2024-11-18 | アップグレード | Goldman | Neutral → Buy |
| 2024-11-15 | アップグレード | Redburn Atlantic | Neutral → Buy |
| 2023-11-09 | 開始されました | Deutsche Bank | Buy |
| 2023-03-27 | 再開されました | Wells Fargo | Overweight |
| 2023-03-17 | 開始されました | Bryan Garnier | Buy |
| 2021-06-14 | アップグレード | Jefferies | Hold → Buy |
| 2021-01-29 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-12-28 | 再開されました | H.C. Wainwright | Buy |
| 2020-07-31 | 開始されました | JP Morgan | Overweight |
| 2020-07-22 | 開始されました | SunTrust | Buy |
| 2020-04-22 | 開始されました | Mizuho | Buy |
| 2019-09-23 | 開始されました | Needham | Buy |
| 2019-05-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-10-24 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Autolus Therapeutics Plc Adr (AUTL) 最新ニュース
Autolus Therapeutics (NASDAQ:AUTL) Sets New 1-Year HighStill a Buy? - MarketBeat
Alphabet Inc. Takes Position in Autolus Therapeutics PLC Sponsored ADR $AUTL - MarketBeat
Autolus Therapeutics (NASDAQ:AUTL) Trading 6.3% HigherStill a Buy? - MarketBeat
Syncona Portfolio Ltd Buys Shares of 16,640,720 Autolus Therapeutics PLC Sponsored ADR $AUTL - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Autolus Therapeutics plc (AUTL) Stock Price, News, Quote & History - Yahoo Finance
Autolus Therapeutics (NASDAQ:AUTL) Trading Down 7%Here's Why - MarketBeat
Autolus Therapeutics (NASDAQ:AUTL) Trading 13.3% Higher Following Strong Earnings - MarketBeat
Renaissance Technologies LLC Has $3.17 Million Position in Autolus Therapeutics PLC Sponsored ADR $AUTL - marketbeat.com
Autolus Therapeutics (NASDAQ:AUTL) Shares Gap UpStill a Buy? - MarketBeat
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Autolus Therapeutics (NASDAQ:AUTL) Trading Down 0.7%Time to Sell? - MarketBeat
AUTLAutolus Therapeutics plc ADR Options - Finviz
Autolus Therapeutics Plc Sponsored ADR Actuals & Estimates (NASDAQ:AUTL) - TradingView
Enterprise value to revenue forward of Autolus Therapeutics Plc Sponsored ADR – TRADEGATE:6A3A - TradingView
Price to book forward of Autolus Therapeutics Plc Sponsored ADR – TRADEGATE:6A3A - TradingView
Price to sales forward of Autolus Therapeutics Plc Sponsored ADR – TRADEGATE:6A3A - TradingView
Price to earnings forward of Autolus Therapeutics Plc Sponsored ADR – TRADEGATE:6A3A - TradingView
Enterprise value to EBITDA forward of Autolus Therapeutics Plc Sponsored ADR – TRADEGATE:6A3A - TradingView
Autolus Therapeutics (AUTL) could find a support soon, here's why you should buy the stock now - MSN
Autolus Therapeutics Receives Prix Galien UK Award - GlobeNewswire Inc.
Autolus Therapeutics (AUTL) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance
Autolus Therapeutics PLC Sponsored ADR (AUTL) Just Flashed Golden Cross Signal: Do You Buy? - sharewise.com
Apellis Pharmaceuticals (APLS) moves 135.4% higher: Will this strength last? - MSN
Autolus Therapeutics Q1 Earnings Call Highlights - Yahoo Finance
Autolus Therapeutics (NASDAQ: AUTL) to cut 13% of staff, save $15M - Stock Titan
Autolus Therapeutics Eyes CAR-T Edge With AUCATZYL Safety, Expands Centers, Sees Margin Turnaround - Yahoo Finance
Autolus Therapeutics (NASDAQ: AUTL) registers $150M shelf for shares, ADSs, debt - Stock Titan
Autolus Therapeutics Highlights obe-cel Momentum in ALL With New Real-World ROKA and Pediatric Data - Yahoo Finance
Apellis Pharmaceuticals (APLS) Surges 135.4%: Can This Momentum Be Sustained? - Bitget
Apellis Pharmaceuticals (APLS) Moves 135.4% Higher: Will This Strength Last? - Yahoo Finance
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Receives $8.50 Consensus Target Price from Analysts - Defense World
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Autolus Therapeutics Q4 Earnings Call Highlights - Yahoo Finance
Mak Capital One LLC Buys 9,062,518 Shares of Autolus Therapeutics PLC Sponsored ADR $AUTL - MarketBeat
Autolus Therapeutics Touts $75M Year-1 Obe-cel Launch, Sees $120M-$135M Revenue in 2026 - Yahoo Finance
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
What is HC Wainwright’s Estimate for AUTL FY2025 Earnings? - Defense World
Q1 Earnings Forecast for AUTL Issued By HC Wainwright - MarketBeat
What is HC Wainwright's Estimate for AUTL FY2025 Earnings? - MarketBeat
New Strong Sell Stocks for January 30th - Yahoo Finance
New Strong Sell Stocks for January 22nd - Yahoo Finance
Why Gelteq Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket - Benzinga
Truist Securities lowers Autolus Therapeutics stock price target on soft guidance - Investing.com
Autolus Therapeutics stock jumps after Needham raises price target - Investing.com
Is Autolus Therapeutics plc (AUTL) The Best Get Rich Fast Stocks to Buy Right Now? - finviz.com
Ryan Richardson joins Autolus Therapeutics board of directors - Investing.com
Autolus Therapeutics plc (AUTL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Are These 4 Biotech Stocks Set to Beat Q3 Earnings Estimates? - Yahoo Finance
Needham Keeps Buy Rating on Autolus (AUTL) with a $10 Target - Finviz
Unlocking Oncology’s Future: 3 Trending Cancer Biotech Stocks with ‘Strong Buy’ Ratings - Barchart.com
Autolus Therapeutics Plc Adr (AUTL) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):